© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
August 31, 2022
Timber Pharmaceuticals’ CONTROL study evaluated the safety and efficacy of the topical isotretinoin.
August 02, 2022
Janssen Pharmaceutical Companies of Johnson & Johnson announced the approval of ustekinumab as a new treatment option for patients aged 6 years or older with active psoriatic arthritis.
July 29, 2022
Arcutis Biotherapeutics’ roflumilast cream will provide relief to patients aged 12 years or older diagnosed with plaque psoriasis.
July 20, 2022
Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.
July 19, 2022
Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.